Primary Biliary Cholangitis - 29 Studies Found
Completed |
: A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid : Primary Biliary Cirrhosis : 2011-07-07 :
|
Active, not recruiting |
: The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland : Primary Biliary Cirrhosis : 2016-07-25 |
Completed |
: Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis : Primary Biliary Cirrhosis : 2008-12-08 :
|
Completed |
: Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis : Primary Biliary Cirrhosis : 2015-09-21 : Dietary Supplement: S-adenosyl-L-methionine Patients will be treated with S-adenosyl-L-methionine, table |
Completed |
: High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis : Primary Biliary Cirrhosis : 2012-05-17 : Dietary Supplement: High protein high fiber diet A personalized high protein high fiber dietary plan wil |
NOT_YET_RECRUITING |
: CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) : : 2024-05-10 : Oral QD |
RECRUITING |
: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis : Primary Biliary Cholangitis : 2024-05-10 : Seladelpar 10 mg one capsule daily for up to 36 months. |
RECRUITING |
: A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis : Primary Biliary Cholangitis (PBC) : 2024-05-10 : Duration: up to an estimated 84-month (7-year) double-blind treatment period during which elafibranor 80 mg tablet will be administered once daily |
RECRUITING |
: IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) : Primary Biliary Cholangitis : 2024-05-10 : Seladelpar 10 mg one capsule daily for up to 52 weeks |